milrinone has been researched along with reserpine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 9 (75.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Belluco, P; Borea, PA; Carpenedo, F; Dorigo, P; Floreani, M; Gaion, RM; Guerra, L; Mosti, L | 1 |
| Belluco, P; Dorigo, P; Gaion, RM; Menozzi, G; Mosti, L; Schenone, P | 1 |
| Belluco, P; Borea, PA; Dorigo, P; Gaion, RM; Maragno, I; Mosti, L | 2 |
| Kamiya, J; Kawai, K; Kobari, T; Maruyama, M | 1 |
| Carpenedo, F; Dorigo, P; Floreani, M; Fraccarollo, D; Gaion, RM; Jester, M; Maragno, I; Mosti, L; Santostasi, G; Schenone, P | 1 |
| Benetollo, F; Bombieri, G; Borea, PA; Dorigo, P; Floreani, M; Fossa, P; Fraccarollo, D; Maragno, I; Mosti, L; Orsini, F; Sansebastiano, L; Santostasi, G | 1 |
| Borea, PA; Dorigo, P; Floreani, M; Fraccarollo, D; Gaion, RM; Maragno, I; Mosti, L; Santostasi, G | 1 |
| Gallagher, WJ; Hebl, JR; Houlton, AJ; Kehler, CH; Soule, CL | 1 |
| Boggia, R; Dorigo, P; Feltrin, A; Lo Presti, E; Menozzi, G; Mosti, L | 1 |
1 review(s) available for milrinone and reserpine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
11 other study(ies) available for milrinone and reserpine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Antagonism towards endogenous adenosine and inhibition of cGI-PDE in the cardiac effects of amrinone, milrinone and related analogues.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adenosine; Amrinone; Animals; Guinea Pigs; Heart; Heart Rate; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Pyridones; Reserpine | 1992 |
Synthesis and cardiotonic activity of 2-substituted 5-cyano-1,6-dihydro-6-oxo-3-pyridinecarboxylic acids and their methyl or ethyl esters.
Topics: Animals; Cardiotonic Agents; Guinea Pigs; Heart; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Nicotinic Acids; Pyridones; Reserpine | 1992 |
An analysis of the mechanism of the inotropic action of some milrinone analogues in guinea-pig isolated atria.
Topics: Adenosine; Adenosine Deaminase Inhibitors; Animals; Carbachol; Cardiotonic Agents; Electric Stimulation; Guinea Pigs; Heart Atria; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Phenylisopropyladenosine; Propranolol; Pyridones; Reserpine; Theophylline | 1991 |
Different action of milrinone analogs in guinea-pig atria.
Topics: Adenosine; Animals; Atrial Function; Brain Chemistry; Chemical Phenomena; Chemistry, Physical; Cyclic AMP; Electric Stimulation; Guinea Pigs; Heart; Heart Atria; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Pyridones; Receptors, Purinergic; Reserpine | 1990 |
Characterization of MS-857, a new and potent cardiotonic agent, in isolated mammalian cardiac muscles.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Carbachol; Cardiotonic Agents; Cats; Cyclic AMP; Cyclic GMP; Dogs; Female; Guinea Pigs; Heart; In Vitro Techniques; Isoquinolines; Macaca mulatta; Male; Milrinone; Myocardial Contraction; Pyridones; Rabbits; Rats; Rats, Inbred Strains; Reserpine; Tetrahydroisoquinolines | 1989 |
Pharmacological characterization of a new milrinone analogue.
Topics: Adenosine Deaminase; Animals; Cardiotonic Agents; Electric Stimulation; Guinea Pigs; Heart Atria; Heart Rate; In Vitro Techniques; Male; Milrinone; Phenylisopropyladenosine; Phosphodiesterase Inhibitors; Propranolol; Pyridones; Reserpine | 1994 |
Synthesis and cardiotonic activity of novel pyrimidine derivatives: crystallographic and quantum chemical studies.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Animals; Atrial Function; Cardiotonic Agents; Cattle; Crystallography, X-Ray; Cyclic Nucleotide Phosphodiesterases, Type 3; Electric Stimulation; Guinea Pigs; Heart Atria; Male; Milrinone; Models, Molecular; Molecular Conformation; Myocardial Contraction; Pyridones; Pyrimidines; Reserpine; Stimulation, Chemical; Structure-Activity Relationship | 1996 |
New inotropic agents: milrinone analogs.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Adenosine Deaminase; Animals; Atrial Function; Binding, Competitive; Cardiotonic Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Electric Stimulation; Guinea Pigs; Heart Atria; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Myocardium; Phenylisopropyladenosine; Phosphodiesterase Inhibitors; Propranolol; Pyridones; Quinolones; Receptors, Adrenergic, beta; Receptors, Purinergic P1; Reserpine | 1997 |
The effect of reduced myocardial cyclic AMP content on the response to milrinone in the isolated guinea pig heart.
Topics: Animals; Cardiotonic Agents; Cyclic AMP; Dose-Response Relationship, Drug; Guinea Pigs; Male; Milrinone; Myocardium; Phosphodiesterase Inhibitors; Pyridones; Reserpine; Sympatholytics | 1997 |
3-Acetyl-5-acylpyridin-2(1H)-ones and 3-acetyl-7,8-dihydro-2,5(1H,6H)-quinolinediones: synthesis, cardiotonic activity and computational studies.
Topics: Adrenergic Uptake Inhibitors; Animals; Cardiotonic Agents; Chemical Phenomena; Chemistry, Physical; Crystallography, X-Ray; Guinea Pigs; In Vitro Techniques; Male; Milrinone; Molecular Conformation; Myocardial Contraction; Quinolines; Reserpine; Structure-Activity Relationship | 1999 |